Sonoma Pharmaceuticals, Inc. (SNOA) › Operating IncomeSonoma Pharmaceuticals, Inc. (SNOA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$7.50M2012: -$6.47M2013: -$3.37M2014: -$6.05M2015: -$6.66M2016: -$14.71M2017: -$12.97M2018: -$14.19M2019: -$11.26M2020: -$7.39M2021: -$3.45M2022: -$5.89M2023: -$4.57M2024: -$4.70M2025: -$3.71M2026: -$2.46M-$2.46M2011Operating Income (USD)2026Fiscal YearOperating IncomeChange YoY2026-$2.46M+33.7%2025-$3.71M+21.1%2024-$4.70M-2.9%2023-$4.57M+22.4%2022-$5.89M-70.7%2021-$3.45M+53.3%2020-$7.39M+34.4%2019-$11.26M+20.7%2018-$14.19M-9.4%2017-$12.97M+11.8%2016-$14.71M-121.0%2015-$6.66M-10.0%2014-$6.05M-79.3%2013-$3.37M+47.8%2012-$6.47M+13.8%2011-$7.50M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share